Kalaris Therapeutics (KLRS) Q1 2025 Earnings

Mar 7Confirmed
Q1 2025
-7.34
-5.81
-4.29
-2.76

Details

Expected EPS
-2.76
Actual EPS
-7.335
Surprise EPS
-4.58
Surprise Percent
-165.76%

Description

⁨Kalaris Therapeutics⁩ (⁦KLRS⁩) has reported earnings of ⁦-7.335⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts